SCHEMBL2990870

SCHEMBL2990870

CN1C=CC(C(N)=O)=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3731943 0.82
SCHEMBL18951822 0.82
SCHEMBL8855876 0.77 LMNA (0.32)
SCHEMBL7035778 0.76
SCHEMBL2997584 0.74 GRM2 (0.35)
SCHEMBL2995311 0.73
SCHEMBL15069806 0.72 MLYCD (0.32)
SCHEMBL2999688 0.69
SCHEMBL17113537 0.68 BCHE (0.34)
SCHEMBL3509200 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104321312-B Chlorination N methyl 4 carbamovl pyridine * and preparation method thereof FARMAK INTERNATIONAL HOLDING GMBH (AT) 2016-11-30 CN claimed
CN-104321312-A N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation FARMAK INTERNAT HOLDING GMBH 2015-01-28 CN claimed
CN-104321312-B Chlorination N methyl 4 carbamovl pyridine * and preparation method thereof FARMAK INTERNATIONAL HOLDING GMBH (AT) 2016-11-30 CN disclosed
CN-104321312-A N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation FARMAK INTERNAT HOLDING GMBH 2015-01-28 CN disclosed
US-20100184811-A1 ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS BRIDGE BIORESEARCH RIGHTS (JERSEY) LIMITED (GB) 2010-07-22 US disclosed
EP-2068873-A2 ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS Pharma 2100 (DK) 2009-06-17 EP disclosed
WO-2008031440-A2 ISONIAZID MEDIATED HEALING OF WOUNDS AND ULCERS PHARMA 2100 (DK) 2008-03-20 WO disclosed
US-5614510-A AMMONIUM SALTS PERSTORP AB (SE) 1997-03-25 US disclosed
WO-1993016705-A1 A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE PERSTORP AB (SE) 1993-09-02 WO disclosed